Changing today to win in the future On 1st April 2017, the GSK Board of Directors made the decision to appoint Emma Walmsley as the first female CEO in the 300-year history of GSK. By many key stakeholders, it was recognised as a controversial decision, inconsistent with GSK and common practices in the UK. She... Continue Reading →